Navigation Links
Cardinal Health Executive Joins Water Street Healthcare Partners
Date:4/8/2009

Hank Struik to Lead Private Equity Firm's Search for Next Medical Products Investment

CHICAGO, April 8 /PRNewswire/ -- Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced today that Hank Struik, a former president with Cardinal Health, Inc., has joined the firm as a senior executive advisor. Mr. Struik, 42, will spearhead Water Street's search for investment opportunities in the growing medical products sector. The firm has provided Mr. Struik with a commitment of up to $100 million of equity capital to kick off the initiative.

"We are excited to work with Hank to build a market-leadership company of lasting value in the multi-billion dollar medical products sector," said Kevin Swan, a partner with Water Street Healthcare Partners. "Since identifying medical products as an attractive health care segment for investment, our team has transformed a number of businesses into leading companies that specialize in products focused on patient safety, rehabilitation and drug delivery. Hank's extensive knowledge and relationships in the medical products sector, combined with our team's deep health care and investment expertise, uniquely positions us to attract the best opportunities."

During his 20-year career with Cardinal Health, Mr. Struik played a lead role in building many of the global health care company's medical products businesses. In 2007, he spearheaded its $1.5 billion strategic acquisition of Viasys Healthcare to establish Cardinal Health as a leader in respiratory care. Mr. Struik, who most recently served as president of Cardinal Health's $850 million dollar Respiratory and Neurocare division, has also held executive positions in sales, marketing, business development and operations.

"As we tapped our national network of health care contacts to search for the best executive t
'/>"/>

SOURCE Water Street Healthcare Partners
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBartle...,slargestmedicalcliniconDec.9-10,whenKansasCityhos...edpeople. ,, "Thisfreecliniceventhasthepotentia...ysinsteadofjustoneandbeheldonweekdaysinsteadofover...tyFreeHealthClinicandpresidentoftheNationalAssocia...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...Researchers have found evidence of a statistically...fen among patients whose estrogen receptor (ER)-po...f ER-alpha; at serine-118 (ER-alpha S118-P), accor...ember 25 in the Journal of the National Cancer In...as are resistant to tamoxifen. Preclinical studies...
(Date:11/25/2009)... Evaluation and treatment c... Woodstock (Vocus) November 25, 2009 -- C...nasal vaccines and H1N1 vaccine shots at four Cent...another shipment of vaccine has arrived. The clini... Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswire/-...reventHealthCareFraudActof2009,"S.2128,whichisdesi...letopreventfraudinMedicare.ThebillwasintroducedbyS...ainsseveralprovisionstheAmericanAssociationforHome...htheAssociationproposedtoCongressinFebruary.Thosep...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...culture had found out a soluble ingredient which w...sorption of the fat at a healthier level. Another ...luble cellulose, reduces the probability of develo... as the one that adds texture. The use of this ing...
...ation (WHO) the apex medical body warns the people... avian influenza or bird flu virus in the area. I... to provide full information to WHO regarding new ... complete the ongoing assessment of the nature of ...
... by Teva Pharmaceutical Industries Ltd. is said to...disease. According to the latest investigatio... physical abilities of patients suffering from Par...ease the extent of motor activities for the patien...
...ription could be used to avoid medical mistakes, b...// may lead to even more errors. It is known th...0,000 people in hospitals each year. One way hospi...ms may actually be leading to more mistakes. Th...
...ther antihypertensive strategies that use calcium ...r to older treatments with beta-blockers and diure... calcium channel blocker amlodipine with or withou... was prematurely stopped after concerns arose that...
...the most common form of brain cancer might fare be...motherapy than radiotherapy alone . Based on fi...ith the type of cancer known as glioblastoma recei...as who were randomized to receive either radiother...
Other Medicine News:
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
(Date:11/24/2009)...PRNewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkS...anizationandDisclosureStatementtoday,November24,20...tofDelaware.AhearingtoconsiderapprovaloftheDisclos...withthehearingontheconfirmationofthePlanscheduledf...payallclaimsinfull.ThePlanisexpected,ifapproved,to...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Scientists pinpoint protein link to fat storage 9969 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 2Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 3Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 4Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 1Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 2Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 3Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 4
...ificantly Improved Key PSG Parameters of Sleep Mai...tudy Ongoing -, SAN DIEGO, June 12 Arena Pharmac...t Dr. Thomas Roth of Henry Ford,Hospital presented...l of,APD125 for the treatment of insomnia in an or...ing of the Associated Professional Sleep Societies...
...GAITHERSBURG, Md., June 12 ,Micromet, Inc. (Nasdaq...irst,patient has started treatment in a multi-cent...ng BiTE(R) antibody blinatumomab (MT103/MEDI-538) ...a (ALL). Blinatumomab is a T,cell engaging antibod...sed,on B cells. The clinical development program f...
Other Medicine Technology:Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 2Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 3Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 4Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 5Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 6Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 6
AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)
AST-GOT
...-line worker" for routine staining protocols frequ...s. It automatically stains big quantities of slide...of reagent stations in combination with a continuo...p to 12 baskets with 30 slides each can be process...
MS/DS 50/100 Slide Stainer
Medicine Products: